Ruslan I. Sadreyev

16.6k citations
158 papers · 7.6k indexed · 3 hit papers · h-index 47

Ruslan I. Sadreyev

153 papers receiving 7.6k citations

Hit Papers

IRF3 and type I interferons fuel a fatal resp...4122009202620142020100200300400500

Peers

Ruslan I. Sadreyev
Comparison fields: 5 of 147
  • Cancer Research 1.2k
  • Aging 143
  • Molecular Biology 5.5k
  • Biological Psychiatry 109
  • Immunology 903
Replace Axel Imhof with:
Axel Imhof Germany
Yutaka Suzuki Japan
James Davie Canada
Annick Harel‐Bellan France
Patrick Matthias Switzerland
Joshua LaBaer United States
Maura Francolini Italy
Tae‐Young Roh South Korea
Stephen Lockett United States
Christopher P. Dillon United States
Ruslan I. Sadreyev relative to Axel Imhof Germany Axel Imhof's profile →
Citations per field
00.5×1.5×2.1×
Axel Imhof · 1×
Citations per year

Countries citing papers authored by Ruslan I. Sadreyev

Since Specialization
Citations

This map shows the geographic impact of Ruslan I. Sadreyev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruslan I. Sadreyev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruslan I. Sadreyev more than expected).

Fields of papers citing papers by Ruslan I. Sadreyev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruslan I. Sadreyev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruslan I. Sadreyev. The network helps show where Ruslan I. Sadreyev may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ruslan I. Sadreyev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ruslan I. Sadreyev Line = papers co-authored together Ruslan I. Sadreyev links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20250
3 20244
4 20241
5 20235
6 202312
7 20232
8 20237
9 20238
10 202224
11 202254
12 202119
13 20216
14 202090
15 2020161
16 202026
17 20196
18 201939
19 201656
20 20158

About Ruslan I. Sadreyev

Ruslan I. Sadreyev is a scholar working on Aging, Molecular Biology and Cancer Research, having authored 158 papers that have together received 7.6k indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (25 papers), Epigenetics and DNA Methylation (21 papers), Genomics and Phylogenetic Studies (18 papers), CRISPR and Genetic Engineering (14 papers), RNA modifications and cancer (13 papers), Machine Learning in Bioinformatics (11 papers), Protein Structure and Dynamics (11 papers) and Enzyme Structure and Function (11 papers). The work is most often cited by research in Cancer Research (1.2k citations), Aging (143 citations) and Molecular Biology (5.5k citations). Ruslan I. Sadreyev has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Nick V. Grishin, Robert E. Kingston, Jeannie T. Lee, Fei Ji, Eda Yildirim, Hongjae Sunwoo, Peggy I. Wang, Murat Çetinbaş, Michael Tolstorukov and Jimin Pei. Their work appears in journals such as Nature, Science and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026